The Combination of PARP and Topoisomerase 1 Inhibitors Improves Radiation Therapy for Ewing Sarcoma
Cancer Science · 2025
DOI: 10.1111/cas.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Jia Xie und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, St. Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Poly(ADP-ribose) Polymerase Inhibitors, Topoisomerase I Inhibitors, Bone Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: St. Baldrick's Foundation, Sarcoma Foundation of America, National Comprehensive Cancer Network Foundation.
Abstract (Originalsprache)
Although primary tumor control rates after surgery and/or radiation therapy (RT) are generally high in patients with Ewing sarcoma (EWS), those with unresectable tumors have failure rates approaching 30% and experience poorer outcomes. Additionally, although metastatic site irradiation is associated with improved survival, dose, and volume effects influence the long‐term toxicity risk. Consequently, it is important to identify novel systemic agents to enhance the therapeutic ratio of RT. Given the reported DNA damage response deficits in EWS, we hypothesized that PARP inhibitors (PARPis) would preferentially potentiate radiation relative to standard‐of‐care (SOC) chemotherapeutics. We investigated primary and recurrent SOC drugs and PARPis with varied trapping potential in combination with radiation in EWS cell lines. At physiologically relevant concentrations, the strong PARP trapper talazoparib (TAL) potentiated radiation to a greater extent than did SOC or other PARPis, although the magnitude of the effect was modest. The radiosensitizing effect of TAL was mediated through the induction of DNA double‐strand breaks, rather than through the catalytic inhibition of PARP1. Drug + RT combinations were further tested in vivo by using orthotopic xenograft models of EWS treated with image‐guided fractionated radiation. The addition of RT to the combination of TAL plus irinotecan (IRN), a recently evaluated clinical regimen for relapsed pediatric solid tumors, significantly prolonged survival and reduced tumor burden in all EWS‐treated mice. This triplet therapy (TAL + IRN + RT) was feasible and yielded responses in several patients with EWS and may represent a useful salvage strategy in recurrent or progressive disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, St. Jude Children's Research Hospital (SJCRH), Memphis, Tennessee, USA.
- Department of Chemical Biology and Therapeutics, SJCRH, Memphis, Tennessee, USA.
- Department of Oncology, SJCRH, Memphis, Tennessee, USA.
- St. Jude Graduate School, SJCRH, Memphis, Tennessee, USA.
- Department of Developmental Neurobiology, SJCRH, Memphis, Tennessee, USA.
- Comparative Pathology Core, SJCRH, Memphis, Tennessee, USA.
ORCID-Profile: Anang A Shelat
Förderung
- St. Baldrick's Foundation
- Sarcoma Foundation of America
- National Comprehensive Cancer Network Foundation
- NCI NIH HHS
- American Lebanese Syrian Associated Charities
- National Cancer Institute
Zitieren
APA
Xie, J., Mellado-Lagarde, M. M., Blankenship, K., Ganguly, D., Twarog, N. R., Bianski, B., Kieffer, M., Atkinson, S., Sheppard, H., Gartrell, J., Cler, S., Federico, S. M., Stewart, E. A., Tinkle, C. L., & Shelat, A. A. (2025). The Combination of PARP and Topoisomerase 1 Inhibitors Improves Radiation Therapy for Ewing Sarcoma. Cancer Science. https://doi.org/10.1111/cas.70042
Vancouver
Xie J, Mellado-Lagarde MM, Blankenship K, Ganguly D, Twarog NR, Bianski B, et al. The Combination of PARP and Topoisomerase 1 Inhibitors Improves Radiation Therapy for Ewing Sarcoma. Cancer Science. 2025. doi:10.1111/cas.70042
BibTeX
@article{Xie2025,
author = {Xie, Jia and Mellado-Lagarde, Marcia M and Blankenship, Kaley and Ganguly, Debolina and Twarog, Nathaniel R and Bianski, Brandon and Kieffer, Matthew and Atkinson, Stefan and Sheppard, Heather and Gartrell, Jessica and Cler, Samuel and Federico, Sara M and Stewart, Elizabeth A and Tinkle, Christopher L and Shelat, Anang A},
title = {The Combination of PARP and Topoisomerase 1 Inhibitors Improves Radiation Therapy for Ewing Sarcoma},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70042}
}
EUVIMED